top of page


Right of Assembly is my personal blog. All opinions are my own. You can read more about me here.


I am a ChromaDex shareholder, and an affiliate marketer. As a result, I will sometimes mention or recommend products that I endorse. I may earn a small commission from qualifying purchases if you were referred directly from this site and completed a purchase. [Thank you!] You can read more about our advertising, privacy, and data collection policies here. 


This site uses cookies. Cookies are not required for site functionality. You can read more about how to opt-out of cookies here.

  • Writer's pictureShelly Albaum

CDXC Short Sales v. Share Price Chart

ChromaDex share price reached about $3.67 on January 6, moments before the news of the Elysium lawsuit was announced in an SEC filing.

Then share price dropped rapidly, stabilizing at around $2.80 in mid-February.

Between mid-February and mid-April, short interest rose from about 1.2M shares to 1.8M shares -- a 50% increase. This correlated with a decline in share price from about $2.80 to about $2.30, roughly 18% decrease.

TL;DR: It appears that litigation drove share prices down in January, but since mid-February the shorts have been responsible for the additional price drops.

255 views0 comments

Recent Posts

See All
bottom of page